SCHEMBL13287028

SCHEMBL13287028

Cc1cc(Cl)c(Cl)c(Cc2c(O)c(Cl)cc(Cl)c2Cl)c1O

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 1/20 0.86
HPGD P15428 7/20 0.77
HSD17B10 Q99714 6/20 0.77
TSHR P16473 4/20 0.77
HIF1A Q16665 4/20 0.77
CYP3A4 P08684 4/20 0.77
POLB P06746 4/20 0.77
SMN1; SMN2 Q16637 3/20 0.77
MEN1 O00255 3/20 0.77
KMT2A Q03164 3/20 0.77
RECQL P46063 3/20 0.77
MAPK1 P28482 2/20 0.77
CYP2C19 P33261 2/20 0.77
CHRM1 P11229 2/20 0.77
ALOX15 P16050 2/20 0.77
TBXA2R P21731 2/20 0.77
ADRA1A P35348 2/20 0.77
HTR2B P41595 2/20 0.77
CASP7 P55210 2/20 0.77
ESR2 Q92731 2/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14644982 0.92 SIRT1 (1.00) SIRT1HPGDHSD17B10TSHRHIF1A
Hexachlorophene SCHEMBL29352805 0.88 HSD17B10 (1.00) SIRT1HPGDHSD17B10TSHRHIF1A
Hexachlorophene SCHEMBL15579 0.88 HSD17B10 (1.00) SIRT1HPGDHSD17B10TSHRHIF1A
SCHEMBL23543131 0.86 SIRT1 (0.89) SIRT1HPGDHSD17B10TSHRHIF1A
Hexachlorophene SCHEMBL16339207 0.86 HSD17B10 (0.95) SIRT1HPGDHSD17B10TSHRHIF1A
Hexachlorophene SCHEMBL2806744 0.86 HSD17B10 (0.95) SIRT1HPGDHSD17B10TSHRHIF1A
Hexachlorophene SCHEMBL3468532 0.86 HSD17B10 (0.95) SIRT1HPGDHSD17B10TSHRHIF1A
Hexachlorophene SCHEMBL2810158 0.86 HSD17B10 (0.95) SIRT1HPGDHSD17B10TSHRHIF1A
Hexachlorophene SCHEMBL19689282 0.86 HSD17B10 (0.95) SIRT1HPGDHSD17B10TSHRHIF1A
Hexachlorophene SCHEMBL11693520 0.86 HSD17B10 (0.95) SIRT1HPGDHSD17B10TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9527878-B2 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-12-27 US disclosed
US-20160009748-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITORS AND METHODS OF USE THEREOF TO MODULATE LIPID METABOLISM THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-01-14 US disclosed
US-9120744-B2 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2015-09-01 US disclosed
US-20100137194-A1 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137194-A1 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism SERPINE1, PLAT, SERPINB1 SIRT1 486/4885HPGD 502/4885HSD17B10 275/4885
US-20160009748-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITORS AND METHODS OF USE THEREOF TO MODULATE LIPID METABOLISM SERPINE1, PLAT, SERPINB1 SIRT1 486/4885HPGD 502/4885HSD17B10 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.